Back to the complete issue
Wednesday, 3 November 2021

Gov’t facilities to close to the unjabbed by next month + kids 15-18 can line up for Pfizer

The unjabbed won’t have access to gov’t facilities starting next month: Starting from 1 December, members of the public will need to show proof that they’ve received at least one dose of a covid-19 vaccine in order to enter government facilities, cabinet spokesperson Nader Saad told Salat Al Tahrir (watch, runtime: 17:10), elaborating on a statement out following the weekly cabinet meeting yesterday.

The lives of unvaccinated public sector employees are going to get harder in less than two weeks: Starting 15 November, unvaccinated state employees won’t be allowed into their workplaces unless they test negative on a PCR test each week, the statement said. Uni students will also be prevented from accessing campus unless they show proof of vaccination.

Children aged 15-18 will be offered Pfizer vaccines in Egypt, acting Health Minister Khaled Abdel Ghaffar said in a cabinet meeting today, according to a statement. Details of the rollout for the age group will be announced within hours, the minister said, adding that unvaccinated university students will not be allowed on campuses as of 15 November.

Some 38 mn doses have now been administered, presidential health advisor Mohamed Awad Tag El Din told Al Hayah Al Youm in a phone call (watch, runtime: 2:23) last night, without disclosing how many people are now fully vaccinated.

The Health Ministry reported 921 new covid-19 infections yesterday, down from 951 the day before. Egypt has now disclosed a total of 332,889 confirmed cases of covid-19. The ministry also reported 58 new deaths, bringing the country’s total death toll to 18,769.


Pfizer has more than doubled its 2021 covid vaccine sales forecast to USD 36 bn, according to its 3Q earnings release (pdf), which showed sales easily beating estimates. The company is also expecting to rake in USD 29 bn in 2022 from its vaccine. One analyst told the FT that the figures demonstrate that the pharm giant is “dominating” the global covid vaccine market.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.